The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of 3-5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: FACS randomized controlled trial.
David Mant
No relevant relationships to disclose
Rafael Perera
No relevant relationships to disclose
Alastair Gray
No relevant relationships to disclose
Peter Rose
No relevant relationships to disclose
Alice Fuller
No relevant relationships to disclose
Andrea Corkhill
No relevant relationships to disclose
Steve George
No relevant relationships to disclose
Louisa Little
No relevant relationships to disclose
Scott Regan
No relevant relationships to disclose
Jane Mellor
No relevant relationships to disclose
Sian Alexandra Pugh
No relevant relationships to disclose
John Northover
No relevant relationships to disclose
Andrew Weaver
No relevant relationships to disclose
Gamal Barsoum
No relevant relationships to disclose
Li Tee Tan
No relevant relationships to disclose
Neil Mortensen
No relevant relationships to disclose
John Scholefield
No relevant relationships to disclose
Harpreet Wasan
No relevant relationships to disclose
David Ferry
No relevant relationships to disclose
John Neil Primrose
No relevant relationships to disclose